152
RMDA: The Pharma Growth Engine 💊🚀

The Driver: High-margin growth in chronic treatments.
Revenue hit EGP 3.95B with steady institutional backing. 📈💰

Sharia Status: ✅ Compliant. A stable member of the EGX33 Shariah Index. ☪️📜

The Valuation: Trades at a premium P/E (~21x), reflecting its faster expansion vs. peers. 💎📊

The Technicals:
the 3.79 EGP level (61.8% Fibonacci). This is the last line of defense for the medium-term bullish structure. 📏🛡️
If 3.79 fails, the price is likely headed for a "Mean Reversion" at the 200-day Moving Average (at 3.4). 🧲📉


The Risk: Vulnerable to API import costs and currency-driven margin squeezes. ⚠️🏗️


If you like my posts, please follow and boost 🙌

Pernyataan Penyangkalan

Informasi dan publikasi ini tidak dimaksudkan, dan bukan merupakan, saran atau rekomendasi keuangan, investasi, trading, atau jenis lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Ketentuan Penggunaan.